Shannon Dallas

2.6k total citations
32 papers, 2.0k citations indexed

About

Shannon Dallas is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Shannon Dallas has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Molecular Biology. Recurrent topics in Shannon Dallas's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (7 papers) and HIV Research and Treatment (6 papers). Shannon Dallas is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (7 papers) and HIV Research and Treatment (6 papers). Shannon Dallas collaborates with scholars based in United States, Canada and China. Shannon Dallas's co-authors include Reina Bendayan, Gloria Lee, M HONG, David S. Miller, Jau‐Shyong Hong, Belinda Wilson, Lyanne C. Schlichter, Michelle L. Block, Wanqin Zhang and Sylvain Baruchel and has published in prestigious journals such as Biomaterials, Brain and The FASEB Journal.

In The Last Decade

Shannon Dallas

32 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shannon Dallas United States 22 636 580 370 354 289 32 2.0k
Xiao‐Yuan Mao China 35 373 0.6× 1.4k 2.5× 314 0.8× 117 0.3× 382 1.3× 99 3.0k
Alberto Lazarowski Argentina 24 625 1.0× 460 0.8× 165 0.4× 559 1.6× 305 1.1× 71 1.8k
Paul D. Drew United States 37 378 0.6× 1.8k 3.2× 1.0k 2.7× 459 1.3× 415 1.4× 72 4.0k
Nathalie Strazielle France 28 603 0.9× 784 1.4× 927 2.5× 687 1.9× 580 2.0× 58 2.8k
Jianxiong Jiang United States 31 325 0.5× 1.1k 1.9× 412 1.1× 216 0.6× 836 2.9× 71 2.8k
Patrick T. Ronaldson United States 30 1.1k 1.7× 979 1.7× 1.4k 3.8× 445 1.3× 307 1.1× 57 3.4k
Regina Rodrigo Spain 29 152 0.2× 869 1.5× 307 0.8× 138 0.4× 470 1.6× 66 2.6k
Masatoshi Tomi Japan 29 635 1.0× 771 1.3× 209 0.6× 530 1.5× 258 0.9× 87 2.2k
Yi‐Chao Lee Taiwan 32 283 0.4× 1.4k 2.4× 208 0.6× 54 0.2× 409 1.4× 90 2.8k
Maxime Culot France 23 473 0.7× 971 1.7× 741 2.0× 96 0.3× 277 1.0× 40 2.2k

Countries citing papers authored by Shannon Dallas

Since Specialization
Citations

This map shows the geographic impact of Shannon Dallas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Dallas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Dallas more than expected).

Fields of papers citing papers by Shannon Dallas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Dallas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Dallas. The network helps show where Shannon Dallas may publish in the future.

Co-authorship network of co-authors of Shannon Dallas

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Dallas. A scholar is included among the top collaborators of Shannon Dallas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Dallas. Shannon Dallas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Coutant, David E., David W. Boulton, Upendra P. Dahal, et al.. (2022). Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development. Clinical Pharmacology & Therapeutics. 113(6). 1185–1198. 11 indexed citations
3.
4.
Mamidi, Rao N. V. S., Shannon Dallas, Carlo Sensenhauser, et al.. (2016). In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin. British Journal of Clinical Pharmacology. 83(5). 1082–1096. 22 indexed citations
5.
Xia, Lei, Xin Hong, Yinghua Qu, et al.. (2015). Cytochrome P450 induction response in tethered spheroids as a three‐dimensional human hepatocyte in vitro model. Journal of Applied Toxicology. 36(2). 320–329. 13 indexed citations
6.
Salphati, Laurent, Xiaoyan Chu, Liangfu Chen, et al.. (2014). Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins. Drug Metabolism and Disposition. 42(8). 1301–1313. 30 indexed citations
7.
Dallas, Shannon, Michelle L. Block, Deborah Thompson, et al.. (2013). Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment. Journal of Neuroinflammation. 10(1). 58–58. 4 indexed citations
8.
Dallas, Shannon, et al.. (2013). Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes. Drug Metabolism and Disposition. 41(4). 689–693. 19 indexed citations
9.
Dallas, Shannon, Carlo Sensenhauser, Monica Singer, et al.. (2012). De-Risking Bio-therapeutics for Possible Drug Interactions Using Cryopreserved Human Hepatocytes. Current Drug Metabolism. 13(7). 923–929. 25 indexed citations
10.
Nugraha, Bramasta, Xin Hong, Wenxia Zhang, et al.. (2011). Galactosylated cellulosic sponge for multi-well drug safety testing. Biomaterials. 32(29). 6982–6994. 49 indexed citations
11.
Xia, Lei, Yinghua Qu, Xin Hong, et al.. (2011). Tethered spheroids as an in vitro hepatocyte model for drug safety screening. Biomaterials. 33(7). 2165–2176. 48 indexed citations
12.
Levesque, Shannon, Belinda Wilson, Shannon Dallas, et al.. (2010). Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity. Brain. 133(3). 808–821. 89 indexed citations
13.
Stadler, Krisztián, Marcelo G. Bonini, Shannon Dallas, et al.. (2008). Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radical Biology and Medicine. 45(6). 866–874. 68 indexed citations
14.
Stadler, Krisztián, Marcelo G. Bonini, Shannon Dallas, et al.. (2008). Direct evidence of iNOS-mediated in vivo free radical production and protein oxidation in acetone-induced ketosis. American Journal of Physiology-Endocrinology and Metabolism. 295(2). E456–E462. 28 indexed citations
15.
Pei, Zhong, Hao Pang, Qian Li, et al.. (2007). MAC1 mediates LPS‐induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity. Glia. 55(13). 1362–1373. 83 indexed citations
16.
Dallas, Shannon, Lyanne C. Schlichter, & Reina Bendayan. (2004). Multidrug Resistance Protein (MRP) 4- and MRP 5-Mediated Efflux of 9-(2-Phosphonylmethoxyethyl)adenine by Microglia. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1221–1229. 73 indexed citations
17.
Dallas, Shannon, Patrick T. Ronaldson, Moı̈se Bendayan, & Reina Bendayan. (2004). Multidrug resistance protein 1-mediated transport of saquinavir by microglia. Neuroreport. 15(7). 1183–1186. 29 indexed citations
18.
Dallas, Shannon, Xiaoping Zhu, Sylvain Baruchel, Lyanne C. Schlichter, & Reina Bendayan. (2003). Functional Expression of the Multidrug Resistance Protein 1 in Microglia. Journal of Pharmacology and Experimental Therapeutics. 307(1). 282–290. 72 indexed citations
19.
Lee, Gloria, Shannon Dallas, M HONG, & Reina Bendayan. (2001). Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations. Pharmacological Reviews. 53(4). 569–596. 454 indexed citations
20.
Stempak, Diana, Shannon Dallas, Julia Klein, et al.. (2001). Glutathione Stability in Whole Blood: Effects of Various Deproteinizing Acids. Therapeutic Drug Monitoring. 23(5). 542–549. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao‐Yuan Mao Breakdown of academic impact, for papers by Alberto Lazarowski Breakdown of academic impact, for papers by Paul D. Drew Breakdown of academic impact, for papers by Nathalie Strazielle Breakdown of academic impact, for papers by Jianxiong Jiang Breakdown of academic impact, for papers by Patrick T. Ronaldson Breakdown of academic impact, for papers by Regina Rodrigo Breakdown of academic impact, for papers by Masatoshi Tomi Breakdown of academic impact, for papers by Yi‐Chao Lee Breakdown of academic impact, for papers by Maxime Culot
Rankless by CCL
2026